Tag Archives: treatment

FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris

FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris NESS ZIONA, Israel, July 27, 2021 (GLOBE NEWSWIRE) — Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced that the Food and Drug… Read More »

Novel dual antibody therapy partially controls virulent HIV infection in monkeys off treatment

A dual therapy of two drugs that are antibodies not to HIV, but to host proteins that help to perpetuate HIV infection, has reduced viral load in monkeys chronically infected with a highly pathogenic monkey analogue of HIV, the 11th IAS Conference on HIV Science was told this week. Zachary Strongin of Emory University in Atlanta, Georgia said… Read More »

FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)

FDA Approves Rezurock (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD) NEW YORK, NY / ACCESSWIRE / July 16, 2021 / Kadmon Holdings, Inc. (Nasdaq:KDMN) today announced that the U.S. Food and Drug Administration (FDA) has approved Rezurock™ (belumosudil) 200 mg once daily (QD) for the treatment of adult and pediatric patients… Read More »

FDA revises labeling of Biogen Alzheimer’s drug to emphasize early treatment

The Food and Drug Administration, under heavy criticism over its decision last month to approve Biogen’s Alzheimer’s drug Aduhelm, has revised the medicine’s prescribing information in an effort to focus treatment on the type of patients included in clinical testing. The FDA’s June 7 approval of Aduhelm was made more controversial by the agency’s decision… Read More »

Weight gain after changing treatment more likely when switching from efavirenz or old-style tenofovir

Gaining weight after switching to a new antiretroviral combination is common, especially after switching from efavirenz or the older formulation of tenofovir, but most weight gain is modest and occurs in the first year after switching, a review of 12 large clinical trials shows. The results suggest that some older antiretrovirals may have a weight-suppressive… Read More »